SCHEMBL26629137

SCHEMBL26629137

CC(OCCS)c1sccc1Br

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ADRA1D P25100 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26629359 0.83 ADRA1D (0.38) ADRA1D
SCHEMBL26629189 0.81 ADRA1D (0.41) ADRA1D
SCHEMBL30635678 0.77 ADRA1D (0.34) ADRA1D
SCHEMBL26779629 0.75 ADRA1D (0.33) ADRA1D
SCHEMBL26629385 0.74 ADRA1D (0.36) ADRA1D
SCHEMBL13919765 0.69 — —
SCHEMBL26629171 0.69 ADRA1D (0.33) ADRA1D
SCHEMBL2478962 0.68 ADRA1D (0.38) ADRA1D
SCHEMBL28811183 0.68 — —
SCHEMBL18003233 0.66 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023215494-A1 THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF ERASCA, INC. (US) 2023-11-09 — — WO disclosed
WO-2023215494-A1 THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF ERASCA, INC. (US) 2023-11-09 — — WO disclosed
Send feedback